CSI Market
Sign In | Register

Iovance Biotherapeutics inc (IOVA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IOVA Annual Balance Sheets →
From Iovance Biotherapeutics inc through Sep 30 2025, shifts in Sep 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/IOVA/balance-sheets
https://api.csimarket.com/api/v1/companies/IOVA/fundamentals
https://api.csimarket.com/api/v1/companies/IOVA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent57.93
Restricted Cash6.02
Short-term Investments, Total0.00
Cash & Short-term Investments57.00
Accounts receivable106.99
Inventories55.22
Other Current Assets0.00
Prepaid Expense And Other Assets Current11.11
Total Current Assets549.64
Equipment/Property/Plant Net189.43
Intangible Assets259.21
Other Assets, Noncurrent305.32
Restricted Cash Current-
Operating Lease Right Of Use Asset44.38
Total Assets991.21
Liabilities
Accounts Payable, Current AC21.65
Accrued Liabilities And Other Liabilities81.69
Notes Payable, Current NO0.00
Other Liabilities, Current2.44
Total Current Liabilities105.77
Total Long-term Debt0.00
Other liabilities, Noncurrent72.78
Operating Lease Liability Current2.90
Operating Lease Liability Noncurrent43.88
Total Liabilities178.55
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock3,722.95
Retained Earnings / Accumulated Deficit-2,924.16
Accumulated Other Comprehensive Income13.85
Other Equity13.85
Common Stockholder's Equity812.66
Total Stockholder's Equity812.66
Liabilities & Stockholder's Equity991.21
4 historic quarters locked

Sign in to unlock the full Iovance Biotherapeutics inc balance sheet history.

Sign In Create Free Account

About Iovance Biotherapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-448809

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI